Diagnostig Limited was established in 2012 as a Point of Care (PoC) diagnostics company. Diagnostig is a spin-out from Bangor University and was created to deliver unique devices for the diagnosis of Mycobacterial infections (including Tuberculosis) based on a proprietary lipid technology.

Diagnostig’s core technology centres on the ability to manufacture specific mycolic acids which are components of the cell walls of mycobacteria. The benefits of this approach include:

  • These unique molecules are potent and selective signalling agents in the immune system
  • They have potential as prophylactic and therapeutic agents and can control asthma in an experimental mouse model
  • They have applications as adjuvants
  • The molecules can be used to identify the serum of people infected with active TB
  • Diagnostig are developing simple devices that can be used without access to a specialist laboratory

Copyright © 2015 Diagnostig Ltd. Company Reg. No: 07975264 VAT No:215835607

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s